Argipressin's Influence on Blood Loss and Inflammatory Response During Hepatic Resection
Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
Infusion of Argipressin during hepatic resection surgery reduces blood loss. It may reduce
transfusion requirements, and mitigate the perioperative inflammatory response compared to
placebo. Subjects will be randomized to infusion of Argipressin or placebo during surgery.
Blood loss, transfusion requirements, inflammatory markers and markers of renal- intestinal-
and cardiac injury will be assessed.